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Introduction 
Obstructive sleep Apnea/Hypopnea syndrome (OSAHS) is one of the 
most important medical conditions identified in the last fifty years. It is a major 
cause of morbidity, a significant cause of mortality throughout the world, and the 
most common medical cause of daytime sleepiness. Central sleep apnea is a less 
common clinical problem. 
As the various ill effects of obesity are becoming increasingly recognized, so 
does the prevalence and the adverse health effects of OSAHS. It is now proven 
beyond doubt that OSAHS plays a significant role in Hypertension, Diabetes 
Mellitus, coronary artery disease, cognitive decline etc. 
But even now in our part of the world, it is a less well recognized and less 
commonly made diagnosis and it is largely overlooked. 
This study is done to see if it is really a commonly occurring problem in 
obese individuals and what are the complications associated with it. 
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AIMS AND OBJECTIVES 
1. To study the occurrence of Obstructive sleep apnea –hypopnea syndrome in 
obese individuals 
2. To study the various complications associated with obstructive sleep apnea – 
hypopnea syndrome and to find their prevalence. 
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Review of literature 
 
Sleep disorders of breathing includes Obstructive sleep Apnea/ Hypopnea 
syndrome (OSAHS) and upper airway resistance syndrome (UARS). Obesity and 
craniofacial dysmorphism are the major risk factors for these syndromes. 
Epidemiology: OSAHS was first recognized during polysomnographic monitoring 
of severely obese patients with the pickwickian syndrome (1). 
      Epidemiological studies based on general population or community based 
cohorts between 30 and 60 years of age estimate that 2-5% of population is 
affected by OSAHS (2-8). It should be noted that these figures mainly applies to 
whites. The incidence may vary in other ethnic groups. The prevalence is twice 
common in women as in men. The syndrome also occurs in childhood usually 
associated with tonsillar or adenoid enlargement and in the elderly the frequency is 
slightly lower. Irregular breathing during sleep without daytime sleepiness is much 
more common, occurring perhaps in one fourth of middle aged males. However as 
the individuals are asymptomatic, they do not have OSAHS and there is no 
evidence as of now that these events are harmful. 
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1. HISTORICAL PERSPECTIVES 
 
1.1 BEGINNING OF THE ERA OF SLEEP MEDICINE: 
        Modern scientific research on sleep patterns and sleep mechanisms began in 
the nineteenth century with the development of electrophysiological tools, needed 
to study small amplitude biopotentials. In 1875 Caton recorded spontaneous 
electrical activity from brains of animals. Brain biopotentials in humans were 
recorded in 1929, by Berger from exposed cortex from patients from whom a piece 
of skull had been removed. He coined the term electroencephalography to describe 
these small biopotentials. Berger reported that the EEG activity was faint when 
subjects were alert and strong when they were relaxed. In 1937 Loomis et al 
reported all- night EEG studies in humans and confirmed Berger’s findings. In 
1953 Aserinsky and Kleiman identified the unique sleep stage, where low voltage 
fast EEG activity occurred with bursts of eye movements. Dement and Kleiman 
recognized it as a state associated with dreaming and coined the term “REM 
(Rapid eye movement) sleep”. 
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The importance of sleep in the pathogenesis and treatment of medical illness 
have been observed from time to time by astute physicians. Beyond these 
observations, discoveries of sleep related changes in basic physiology and their 
possible role in the pathogenesis of disease awaited the era of modern 
electrophysiology. The discovery of REM sleep in the 1950s along with the 
automatic alterations associated with this state showed that important physiological 
changes are associated with sleep. The decade of 1960s witnessed very little 
interest in medical as opposed to psychiatric application of sleep research. With the 
discovery of sleep related breathing disorders in the 1960s, the attention was then 
focused to variety of different sleep related breathing disorders in children and 
adults. 
 
1.2 HISTORICAL ASPECTS OF OBSTRUCTIVE SLEEP APNEA 
SYNDROME 
The syndrome of obstructive sleep apnea provides a unique example of those 
disorders where a syndromic description of the disease existed long before its 
scientific documentation.  First described by Charles Dickens in the posthumous 
papers of the Pickwickian club, in 1837, a boy named Joe. Joe was described as an 
extremely fat, persistently hypersomnolent character. The term “Pickwickian 
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syndrome” derives from this. In 1889 observations were made by the British 
physician Caton and French man Lameq that certain people with excessive daytime 
somnolence tend to have periods of suffocation during sleep. The term 
‘Pickwickian’ was first coined by Sir William Osler in 1918, to describe obese, 
hypersomnolent patients. Observations were made in 1939 by Kerr and Langer that 
such patients develop cardio respiratory problems, like Cor pulmonale and cadiac 
failure. The principal clinical features of the Pickwickian syndrome were reviewed 
by Burwell et al in 1956, Belner in 1954 and 1962. Alexander and colleagues 
described a ‘Joe’ type of Pickwickian characterised by Obesity and 
hypersomnolence alone. Repeated attacks of obstructive sleep apnea were noted to 
occur in these Pickwickian by Gastaut and colleagues in 1964-65.  The first case 
report of a patient with presumed Obstructive sleep Apnea was presented by jung 
and Kalls in 1965, remarking that the patient had sleep apnea for 10 years prior to 
the development of the Pickwickian syndrome. The first cinematographic study of 
obstructive sleep apnea was done by Schwartre and Scanele in 1967, when the 
oropharyngeal collapse during apneic episodes was demonstrated. The first 
international meeting on ‘Hypersomnolence and periodic breathing’ was organised 
in 1972 by Lugaressi and Sadenil. In the decade that followed clinicians started 
applying their knowledge of sleep physiology to the sleep apnea syndrome and 
tracing the various components underlying the syndrome (9). 
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By the early 1980s a methodology to study sleep had been described in detail.  
The description of these sleep related phenomenon accomplished two goals in 
identifying sleep as a legitimate area of medicine and science:  
1. Sleep was objectively described by measurable physiologic changes. 
2. Unique physiological changes specific to sleep were identified. 
  
2. PHYSIOLOGICAL ASPECTS OF SLEEP 
 
2.1CLASSIFICATION OF SLEEP WAKEFULNESS STAGES 
The most widely accepted classification system in use today is that of 
Rechscaffen and Kales. An important premise of this scoring system is that REM 
sleep, NREM sleep and wakefulness are fundamentally different stages of 
consciousness, as determined by both electrographic and physiologic variations. 
The essential electrographic parameters used in the determination of sleep 
stages are the electroencephalogram (EEG), electrooculogram (EOG) and 
electromyogram (EMG). Briefly the Rechschaffen and Kales guidelines for 
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assigning sleep stage classification to each 20-60 seconds scoring epoch is as 
follows: 
Waking:  The EEG activity during alert wakefulness predominantly consists 
of low amplitude, high frequency (13-35 Hz) beta activity, accompanied by high 
EMG activity and frequent eye movements. With relaxation a sinusoidal alpha 
activity (8-13Hz) is superimposed on the β pattern. As the subject changes from 
relaxed, alert condition to drowsiness, the EEG activity slows to a frequency nearer 
the end of alpha range. 
STAGE 1 NREM SLEEP: This is a transitional stage between waking and sleep 
that typically lasts 1-7 minutes. The EEG shows low amplitude, mixed frequency 
activity in the beta and theta (4-7Hz) range. Later slower frequencies begin to 
predominate and high amplitude (up to 200 µv) vertex sharp waves may appear. 
EMG activity is usually higher than other sleep stages. EOG often shows 
disconjugate slow rolling eye movements lasting 1 second or more. 
STAGE 2 NREM SLEEP: This stage is recognized by the presence of sleep 
spindles and ‘K’ complexes. Sleep spindles are sinusoidal rhythm (12-20Hz) of 
brief duration. The K- complex is a high amplitude negative sharp wave followed 
immediately by a slower positive component. 
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STAGE 3 NREM SLEEP: This stage is recognized by the presence of high 
amplitude slow wave (greater than 75µv) peak to peak, 2Hz or slower, appearing in 
20-50% of the scoring Epoch. EMG activity is usually low and eye movements are 
absent. 
 
STAGE 4 NREM: This stage is defined by the presence of slow waves in more 
than 50% of the Epoch. Stage 3 and 4 are often combined. 
NREM is a physiologically quiet and stable stage. Heart rate and respiration tend 
to be slower and regular and muscles relaxed. 
REM SLEEP: The EEG during REM sleep consists of mixed frequency, low 
voltage activity closely resembling the EEG of stage 1 NREM. REM sleep is 
characterized by a broad spectrum of physiological changes. EMG activity is 
lowest and rapid conjugate eye movements occur throughout the REM periods. 
‘Phasic’ episodes within the REM sleep are characterized by high degree of 
autonomic variability, including elevated and irregular heart rate, respiratory rate 
and blood pressure. During ‘Tonic’ REM sleep these variables are more constant 
(10). 
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2.2 PHYSIOLOGIC VARIATIONS OF CARDIORESPIRATORY 
PARAMETERS DURING SLEEP. 
2.2.1 SLEEP AND BLOOD PRESSURE 
Early studies employing indirect methods to record Blood pressure (BP) 
documented consistent but variable reduction in systemic blood pressure during 
sleep. Synder et al first correlated EEG with respiration, heart rate and systolic BP 
measured at 5 minutes intervals with a sphygmomanometer in 12 healthy subjects 
during 2-3 nights of uninterrupted sleep (11). They described a fall in blood 
pressure averaging 20% to a minimum about 2 hours after the beginning of sleep, 
with gradual rise by rest of the night to a level comparable to that at sleep onset. 
Richardson et al also correlated the EEG with Blood pressure and heart rate and 
noted that waking even for brief periods always resulted in elevation of BP and 
Heart rate(HR) which coincided with the occurrence of the α rhythm and averaged 
13/11 mmhg and 5 beats/minute respectively (12). Smyth et al further 
demonstrated that there is no nocturnal rhythm of BP independent of sleep (13). As 
early as 1912, Brookes and Carroll noted that frequent interruptions in sleep 
prevented the fall in BP (14). Litter et al measured continuous intra arterial BP in 
27 unrestricted volunteers and demonstrated that irrespective of the use of 
antihypertensive drugs, the blood pressure falls during sleep and rises on 
awakening and continues to rise with physical activity. The mean arterial pressure 
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was found to decrease by an average of 5-9% during NREM sleep stages 3 &4, 
when compared to awake resting stage. During REM sleep, BP fluctuated 
considerably and averaged values about 5% greater than immediately preceding or 
succeeding values during NREM(15).With the availability of ambulatory blood 
pressure monitoring devices, the data on the blood pressure variability throughout 
the day and night became available. During such measurements the blood pressure 
is found to dip by 5-10% towards the later part of the night (16). 
 
2.2.2 SLEEP AND HEART RATE: 
Heart rate normally decreases by 5-8% during NREM sleep. During REM 
sleep heart rate is variable with the mean rate approximating the resting awake 
values (17). 
 
CARDIAC ARRYTHMIAS DURING SLEEP  
   The prevalence of cardiac arrhythmias has been evaluated in young, middle 
aged and elderly normal subjects using Holter monitoring. The results have 
indicated that ventricular ectopic activity is frequently observed in normal 
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population; its prevalence increases with age. Most of the studies show a decrease 
in the frequency of ventricular ectopy during sleep (18, 19, 20, and 21) 
Sinus arrhythmia was found to be the most frequent nocturnal dysrrhythmia 
occurring in 50% of young men. About 30% had sinus pauses of 1.8-2.6 seconds 
duration and 6% had episodes of first degree block (18). The prevalence of 
bradyarrythmias tend to decrease with age and is lower in females (19, 20,22). 
3. OBESITY AND SLEEP APNEA 
 
3.1 EPIDEMIOLOGIC DATA: 
In his review of sleep apnea syndromes Guilleminault found that 20% of the 
subjects had normal weight, another 20% were 15% or less overweight, 30% were 
16-30% overweight and 40% were 31-400% overweight. Thus approximately 70% 
of the patients were found to be obese (23). Boudoulas studied 120 consecutive 
patients referred with excessive daytime sleepiness and concluded that patients 
with sleep apnea were usually obese (24). In another study the prevalence of OSA 
in obese middle aged men, who had been selected for weight reduction surgery 
was found to be 38%, most of whom were symptomatic (25). 
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3.2 MECHANISMS: UPPER AIRWAY STRUCTURE 
Obstructive sleep apnea occurs because of recurrent occlusion of the upper 
airway during sleep. Upper airway imaging techniques (eg. CT scanning of the 
pharynx), have provided important insights into the pathogenesis of OSA (26). 
Lateral cephalomerty has evolved as a simple and well standardized imaging 
technique consisting of radiograph of head and neck with specific emphasis on 
bony and soft tissue structures (27). Cephalometry has demonstrated a variety of 
abnormalities of craniofacial and upper airway soft tissue anatomy that may 
predispose patients to upper airway obstruction during sleep and that are also 
related to severity of OSA. Patients with OSA have been shown to have, small 
posteriorly placed mandible, a narrow airway space, an enlarged tongue and soft 
palate, and an inferiorly placed hyoid bone. Posterior hyoid space, hyoid position 
and soft palate and tongue size have all been shown to be significant determinants 
of apnea severity (18, 28, 29, 30). It remains unclear whether craniofacial 
abnormalities or soft tissue changes are the most important determinants of OSA in 
most patients. 
Obesity occurs in most patients with OSA and is considered to be a major 
risk factor for its development.  Neck circumference (NC) is a simple clinical 
measurement that reflects obesity in the region of the upper airway. Patients with 
OSA have been shown to have thick necks when compared with both non-apneic 
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snorers and weight matched controls (29, 31). Furthermore NC correlates with 
several soft tissue variables, measured from lateral cephalometry, and correlates 
better than body mass index with apnea severity (31). This suggests that obesity 
mediates its effect in OSA through fat deposition in the neck. However not all 
patients with OSA are obese, Ferguson et al found that in comparison to obese , 
patients with OSA , who have increased upper airway soft tissue, non obese OSA 
patients have abnormal craniofacial structure, as detected by lateral cephalometry 
(32). 
 
3.3 DISTRIBUTION OF BODY FAT AND GENDER DIFFERENCES 
    Studies have shown a difference in the prevalence of OSA in men and women of 
equivalent BMI. Rajala et al studied 13 men and 14 women of BMI approximately 
40kg/m2 and found the occurrence of OSA to be 76.9% in men and 7.1% in women 
(33).  This suggests that the differences in fat distribution in men and women 
contribute to the differences in the development of OSA. Millman et al found a 
greater degree of upper body obesity, as reflected by higher waist to hip ratio, 
subscapular skin fold and neck circumferences and smaller hip circumferences in 
men. The men also had more severe degree of OSA compared to women (34). 
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   Differences in body fat distribution may not be the only factor causing gender 
differences in the occurrence of OSA. Schewas et al using cine computed 
tomography found that in men the change in pharyngeal area is larger with 
changing lung volume, implying a greater tendency for the airway to collapse (32). 
   An alternate explanation is in the gender related differences in the ventilatory 
control that predisposes obese men rather than obese women to develop OSA (35, 
36). 
3.4 WEIGHT REDUCTION AND OSA 
Further information in the role of obesity in the sleep apnea has been gained 
by doing sleep studies on obese patients with obstructive apnea before and after 
weight loss. Methods reported for weight loss among patients with obstructive 
sleep apnea have included ileal bypass, gastric partitioning or gastroplasty and 
starvation. These reports in general have shown a marked improvement in patients 
symptomatically, especially decreased somnolence, a decrease in the number of 
apnea episodes and improvement in oxygenation of the patient (37, 38). Block felt 
the improvement in four morbidly obese patients who had lost an average of 108 
kg was so marked that it proved obesity was a cause than an effect of the sleep 
apnea syndrome (38). 
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Orr et al reported that patients who were hypersomnolent and had 
obstructive sleep apnea weighed more, had lower waking arterial O2, during sleep, 
than did the asymptomatic patients with a comparative degree of obstructive sleep 
apnea (39). Losing weight often corrects hypoxemia in obese patients. Apart from 
apnea, hypoxemia in obese patients occurs because of the alveolar hypoventilation 
related to elevated diaphragm and further mismatch of ventilation and perfusion in 
supine position. 
    Not all studies have found weight reduction helpful in the treatment of 
obstructive sleep apnea. The weight loss was noted to be partial and temporary in 
one review. In a second series it was found to have no effect on clinical symptoms 
or respiration. The amount of weight loss might not have been sufficient (40). 
 
3.5 ROLE OF ENDORPHINS AND ENCEPHALINS:   Another new area of 
research to link obesity, sleep apnea and alveolar hypoventilation are the 
endorphins and encephalins. Marguls et al found elevated concentration of β-
endorphins in the pituitaries of obese mice (41). The endogenous opioids have 
been considered to control the initiation of feeding drive especially during stress 
inducing stimulus. McCloy and McCloy postulated that obesity was simply an auto 
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addiction to the endogenous opioid peptides. O’Brien found a relationship between 
endorphin activity and human obesity (42). 
    Endorphins have been related to changes in ventilatory drive, causing 
bradypnea, apnea and hypo-ventilation. Β-endorphin injected intracisternally in 
lightly anaesthetized dogs resulted in marked respiratory depression and 
diminished ventilatory response to carbon dioxide in one study (43). The elevated 
β-endorphin levels found in the brains of obese people may play a role in lowering 
the threshold for development of hypoventilation during sleep. These postulates 
need further investigation. 
 
4. SLEEP APNEA AND HYPERTENSION 
Sleep apnea and systemic hypertension are common health problems 
affecting the middle aged and older population. Though common in males the 
prevalence of both hypertension and sleep apnea in post menopausal women nearly 
equals that of men of same age. Many recent reports noted increased risk of 
systemic hypertension in sleep apnea syndromes. It has been suggested that apnea 
lead to sustained daytime elevation of blood pressure and ultimately hypertension. 
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4.1 THE APNEA HYPERTENSION CORRELATION 
    Sleep apnea and hypertension are linked by epidemiological studies. About 50% 
of all patients with sleep apnea are hypertensives (44, 45). Conversely prevalence 
of sleep apnea in patients with hypertension approximates about 30 %( 46, 47, 48). 
Despite this association, apnea has not been proved to be a direct causal factor for 
hypertension. The cause effect relationship is further compounded by factor of age, 
and presence of obesity both of which affect the incidence of sleep apnea. 
   In contrary to the normal dip in BP in normal and hypertensive individuals, the 
BP in patients with sleep apnea may fail to dip. The BP rises slowly throughout the 
night in such patients. This pattern is also observed in preapneic snorers (49). This 
causal role of apnea in hypertension in some treated apnea patients (50, 51, 52). In 
the study by Fletcher et al, 8 males experienced a lowering of BP from 149/95 to 
139/90 without antihypertensive medications after treatment of sleep apnea (53). 
Guilleminault described two children with sleep apnea in whom tracheostomy 
reduced BP from 150/100 and 160/105 to 120/80 and 125/80 respectively. There 
have been reports of lowering of BP in patients with sleep apnea treated with nasal 
CPAP. Wilcox examined systolic BP in 19 subjects treated with nasal CPAP for 8 
weeks and found a reduction in BP in both normotensive and hypertensive subjects 
(54). 
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4.2 EPIDEMIOLOGIC EVIDENCE OF CASUALTY 
The first study to examine apnea as a potential cause of primary 
hypertension included 16 hypertensive subjects where clinical histories suggested 
sleep apnea. Eleven were found to have more than 10 apneic events/hr (40). Since 
this lacked age, weight and sex matched controls, the importance is partially 
compromised. 
Kales et al subsequently performed polysomnography in 50 Hypertensive 
and 50 normotensive patients matched for age but not weight. Fifteen (30%) of the 
hypertensive subjects were diagnosed as having sleep apnea with mean index of 
22.4events/hr (47). Fletcher et al examined the prevalence of sleep apnea in 46 
men with essential hypertension and 34 normotensive men matched for age and 
weight. Fourteen hypertensive men and 3 controls had sleep apnea defined as more 
than 10 apnea/hr (53). Williams et al studied 23 hypertensive subjects and 8 age 
and weight matched normotensive subjects and found that 35% of the hypertensive 
subjects had sleep apnea. Hypertensive subjects were removed from medications at 
the time of study and patients with apnea were more obese than patients without 
apnea (53). 
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Some other studies have not demonstrated a higher prevalence of apnea in 
hypertensive population. Hirshkowitz et al found no difference in apnea index 
between 38 untreated hypertensive and 53 normotensive males (55). Warley et al 
recorded overnight arterial desaturations at home in 30 men with untreated 
essential hypertension and compared the data to 30 normotensive controls, 
matched for age, height and weight (56). These were not full polysomnographic 
studies and respiration was not monitored. 
A study by Hofstein et al supports the association between self reported 
snoring and systemic hypertension. They studied 1415 patients; Multivariate 
regression analysis showed age, male sex, AHI and BMI to contribute to variability 
in BP. It concluded that snoring in absence of apnea does not contribute to 
hypertension (57). 
Hia et al studied ambulatory BP measurements during an entire 24 hr period 
in 147 patients and compared the pattern in patients with OSA and in non apneic 
snorers, with the general population. They found an association between 
hypertension and sleep apnea independent of age, obesity and sex (58). More 
recently Pankov et al also used 24 hour BP monitoring at 15 minute intervals in 93 
subjects and found an association between nondipping and apnea severity (58). 
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  In summary, the epidemiological evidence implicating apnea as a cause of 
primary hypertension remains controversial some studies have been done without 
normotensive controls matched for weight making it impossible to sort out the 
effect of obesity as a contribution for both these diseases. In studies where subjects 
remained on hypertensive drugs, the possibility remains that the drugs contributed 
to the disordered breathing during sleep. 
 
 
 
4.3 APNEA IN ACUTE BP ELEVATION 
4.3.1 ACUTE CHANGES ASSOCIATED WITH APNEA: 
    Apnea exerts several acute cardiothoracic, neural and hemodynamic effects. 
They are: 
a) Wide fluctuations in intrathoracic pressure to values as low as -90cmH2O 
b) Gradual lowering of blood oxygen and rise in blood carbon dioxide level 
with resultant stimulation of peripheral chemoreceptors 
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c) Vagal hypertonia associated with hypoxemia and stimulation of  
baroreceptors resulting in slowing of heart rate 
d) Decreased stroke volume ( right ventricular overfilling with septal shift) 
e) Increased afterload (greater transmural pressure) from the deep negative 
intrathoracic pressure 
f) Surge of sympathetic activity to vascular smooth muscle causing 
vasoconstriction in certain vascular beds. 
With resumption of normal breathing, release of bradycardia, normalization of 
right ventricular preload and release of left ventricular afterload contributes to 
sudden increase in cardiac output. When the larger blood volume meets the 
constricted peripheral vascular bed, an acute post apneic increase in blood pressure 
occurs (59, 60). 
4.3.2 EFFECTS OF ACUTE HYPOXEMIA 
  The most striking acute pathophysiologic change during sleep apnea in 
humans is episodic hypoxemia, often to SaO2 levels below 50% and PaO2 levels 
less than 30mmHg. 
In patients with severe apnea, urinary catecholamines are found to be 
elevated (61). Using microneurography, it was found that acute hypoxia which 
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elevates blood pressure also elevates postganglionic sympathetic activity(62).Such 
evidence suggests that  diurnal elevation in blood pressure might be mediated by 
recurrent chemoreceptor activation and increased/ prolonged sympathetic nerve 
activity. 
 
4.3.3 ACUTE HYPOXEMIA DURING HUMAN APNEA 
  Indirect evidences indicate hypoxia as the main trigger for acute blood 
pressure elevation during apnea. Shepherd observed repetitive apneas in 10 
subjects while measuring intra-arterial blood pressure. He noted an apparent 
positive relationship between oxyhemoglobin desaturation and blood pressure 
elevation with a correlation co-efficient of 0.58 in some individuals (63). Van den 
Aardweg and Karemaker asked males to simulate apnea by holding their breath 
voluntarily under hypoxic conditions (allowing desaturation). The blood pressure 
in these subjects rose to abnormal values (mean> 150/90 mmHg) during hypoxic 
stimulation but remained stable during hyperoxic ones (64). The finding indicates 
that hypoxia was a necessary component for an intra-apneic rise in blood pressure. 
Lavie et al applied automated 24 hr BP monitoring to 38 patients with 
Obstructive sleep apnea. They found that Apnea- Hypopnea index, age total sleep-
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time and minimal level of apnea desaturation accounted for 52% and 54% of the 
total variance in diastolic and mean 24 hr blood pressure respectively (65). 
Hedner et al documented similar correlation between nadir oxyhemoglobin 
desaturation in 17 apneic subjects. The same study demonstrated that patients with 
obstructive sleep apnea, regardless of their resting blood pressure, have an 
increased pressure response to induced hypoxia compared to non- apneic controls 
(66). 
Some investigators doubt about the role of hypoxia alone as the major 
inducer of blood pressure elevation in the setting of sleep apnea. In one study, the 
authors investigated the effect of non specific arousal from sleep on acute blood 
pressure changes. Bursts of auditory stimuli during sleep acutely elevated systemic 
blood pressure upto 20% in 5 normal adults (67). Ringer et al also attributed blood 
pressure elevation following apnea to arousal rather than hypoxia (68). 
 In summary, although many factors may play roles in the acute blood 
pressure elevation during apnea, the best investigated one is acute hypoxia. 
Some studies show correlation between the level of acute blood pressure elevation 
and degree of hypoxemia; the authors question hypoxia as a major determinant in 
acute hemodynamic response to apnea and suggest other mechanisms such as 
arousal. 
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4.3.4 APNEA AND CHRONIC BP ELEVATION 
A number of factors associated with sleep apnea are thought to play a role in 
the mechanisms for long term diurnal blood pressure elevation. They are: 
a) The direct effect of episodic hypoxia and hypercapnia on 
chemoreceptors and sympathetic activity. 
b) Modification of the cardiovascular system (including fluid balance) 
in response to marked fluctuation in negative intrathoracic pressure, 
during obstructed breathing. 
c) Generalized  stress from disruption of sleep 
d) Genetic factors 
e) Age 
 
4.3.4 .1 THE ROLE OF CHEMORECEPTORS 
Chemoreceptors adapt in a long term fashion to hypoxia and hypercarbia and 
play a role in determining baseline blood pressure. It has been demonstrated that 
young subjects with mild hypertension have an increased ventilatory and pressure 
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responsiveness to isocapneic hypoxia. Augmented resting ventilatory drive 
dependent on peripheral chemorecptors has been documented in hypertensive 
subjects, and potentiation of excitatory sympathetic nerve responses to hypoxia has 
been shown in borderline hypertensive subjects. 
It has been hypothesized that long term episodic hypoxia during obstructive 
sleep apnea resets the chemoreceptor reflex drive to a higher level, causing a 
chronic increase in sympathetic tone and initiating hypertension (59, 60 ). 
 
4.3.4.2 THE SYMPATHETIC NERVOUS SYSTEM IN ACUTE APNEA  
Using microneurography of perineal muscle nerves during obstructive and 
non-obstructive apneas in humans, Hedner et al demonstrated that sympathetic 
nerve activity increased markedly throughout the course of apnea, reaching a peak 
at the onset of ventilation followed by an abrupt drop (69). 
Fletcher et al demonstrated elevated nor epinephrine and not metanephrine 
in patients with severe apnea, with normalization after tracheostomy (70). 
Mannone et al demonstrated that both nor epinephrine and epinephrine were 
elevated at night in subjects with obstructive sleep apnea. Only epinephrine 
excretion decreased on the subsequent night with elimination of apnea by nasal 
CPAP (71). 
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The contribution of hypoxia in causing increased sympathetic nerve activity 
is demonstrated in a study by Somers et al. using perineal nerve recording in 
normal humans the authors demonstrated increased activity during induced 
hypoxia and stimulated apnea (72). 
Apnea may enhance sympathetic activity via the Bainbridge reflex, as a 
result of increased right atrial filling. (Muller’s maneuveur) and hypoxic 
pulmonary vasoconstriction (73). 
 
 
 
4.3.4.4 CHEMORECEPTORS AND SYMPATHETIC RESETTING 
  Recent studies establish that the peripheral sympathetic activity may 
continue long after cessation of hypoxemia. Crabtree et al administered 
intermittent asphyxia to 5 healthy awake subjects over a 20 minutes period. Muscle 
sympathetic nerve activity increased throughout the period of asphyxia and 
remained elevated above control levels for upto 20 minutes after the release of 
stimulus. The authors hypothesized that carotid chemoreceptors are sensitized to 
hypoxia (74). This fits well with theories that sympathetic activity to adrenals or 
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peripheral vasculature promotes diurnal elevation of blood pressure, by remaining 
high long after the nocturnal episodic asphyxia stimulus is terminated. The final 
link is the activation of an endogenous organ vasoactive amine, such as vascular 
wall angiotensin, cleared from the arterial wall in response to repeated 
vasoconstriction - relaxation, which may lead acutely to vasoconstriction and 
chronically to smooth muscle hypertrophy and a more permanent form of 
hypertension (75). 
 
4.3.4.5 THE ROLE OF AGE AND GENETICS 
Age also plays a role in the pathogenic effect of hypoxia on the 
cardiovascular system. This is suggested by animal experiments (76). 
Hypothetically younger humans may develop less blood pressure elevation in 
response to chronic episodic asphyxia than older individuals. Middle aged and 
older individuals might then be more susceptible to develop hypertension with 
sleep apnea and less likely to revert to normal blood pressure after elimination of 
apnea. 
 
4.3.4.6 EFFECT OF NON SPECIFIC STRESS 
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Behavioural stress in many forms has been shown to induce acute 
cardiovascular responses. Chronic stress and increased sympathetic nerve activity 
may contribute to primary hypertension. Thus a more general response to stress, 
including disruption of sleep architecture and reduced sleep efficiency could 
promote elevated blood pressure in episodic hypoxia. 
 
5. PULMONARY HYPERTENSION IN OBSTRUCTIVE SLEEP APNEA: 
In 1998, the world health organization  conference on  Pulmonary arterial 
hypertension (PAH) (77) recognized sleep disordered breathing as a secondary 
cause of PAH,  PAH may be defined as an elevation in the mean pulmonary 
arterial pressure to atleast 20 mmHg at rest or 30 mmHg during exertion. PAH is 
usually mild although it could also be severe, resulting in cor pulmonale, a feature 
of pickwickian syndrome. 
Since the study of Tilkian and colleagues (78) many studies have 
demonstrated that PAH is relatively common in patients with OSA (79) 
  Multiple mechanisms mediate nocturnal rise in pulmonary arterial pressure. 
These include alterations in blood gases, cardiac output lung volume etc. Diurnal 
PAH could be precapillary, capillary or postcapillary depending on the co-morbid 
conditions that may contribute to the development of PAH in OSA. Post capillary 
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PAH could be due to left ventricular hypertrophy and diastolic dysfunction caused 
by diurnal systemic hypertension. Loss of vascular surface area as may occur in 
COPD is an important cause of capillary PAH. Another important mechanism 
contributing to or mediating PAH in OSA is the presence of factors that cause 
constriction of pulmonary arterioles, typically due to hypoxia. The molecular 
mechanisms behind these are complex and multifactorial. 
 
 
 
 
6. SLEEP APNEA AND GLUCOSE METABOLISM: 
6.1 DIABETES AS A CAUSE OF SLEEP APNEA 
Many studies have suggested that diabetic patients with autonomic 
neuropathy were more likely to manifest obstructive or central sleep apnea or both 
than those without autonomic neuropathy (80). Given that normal breathing during 
sleep is dependent on central respiratory motor control and upper airway patency, a 
major implication of the earlier reports is that central and OSA might be a 
consequence of autonomic dysfunction. More recently data from sleep heart health 
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study has provided compelling evidence for an independent relationship between 
sleep apnea and type 2 Diabetes (81) in a large cohort of community dwelling 
individuals without cardiovascular disease. 
 
6.2 SLEEP APNEA AS A CAUSE OF DIABETES: 
       A growing body of evidence suggests that sleep apnea may independently 
contribute to the incidence of Type 2 Diabetes. Perhaps the best evidence for a 
causal link is found in two recent cohort studies that assessed the association of 
type 2 Diabetes (82). In the first study, habitual snoring in 2668 Swedish men was 
associated with a higher incidence of self reported diabetes over a 10 year period 
(82). The subsequent Nurses’ health study (82) showed that the relative risk for 
Diabetes comparing snorers to non snorers was 2.03. Thus it remains to be seen 
whether sleep apnea mediates the observed association between snoring and the 
occurrence of type 2 diabetes Hypoxia and sleep fragmentation are the major 
mechanisms proposed to explain the association. 
 
7. OSA AND LEFT VENTRICULAR SYSTOLIC/DIASTOLIC DYSFUNCTION 
 7.1 OSA AND SYSTOLIC HEART FAILURE 
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In humans, there are 2 kinds of studies relating left ventricular systolic 
dysfunction and OSA. First, studies in which patients with OSA have been 
assessed for the presence of left ventricular dysfunction(83-86) and second , 
studies  assessing the prevalence of OSA in patients with established LV systolic 
dysfunction(87, 88). Both the studies have pointed to a significant correlation. Use 
of radionucleotide ventriculography is important because in obese subjects, using 
ECHO may be associated with technical difficulties. 
          The mechanisms by which OSA may impair LV systolic function are 
multiple. Hypoxia plays a critical role both by impairing myocardial contractility 
and through a host of other neurohumoral mechanisms. 
 
       7.2 OSA AND DIASTOLIC HEART FAILURE 
Isolated LV diastolic failure with relative preservation of LV systolic 
function is the most common form of heart failure in elderly subjects.  The 
pathophysiologic consequences of this form of heart failure relate to a 
hypertrophied non compliant LV. 
Hemodynamic studies (89, 90) of patients with OSA have documented that 
pulmonary capillary pressure increases during the course of an obstructive apnea, 
indicating development of diastolic dysfunction. During obstructive apnea, LV 
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transmural wall thickness increases. This along with the hypoxemia may impair 
LV relaxation which impairs diastolic function (91). Repeated exposure to 
nocturnal hypertension and consequent development of OSA induced systemic 
hypertension and increased LV mass may also contribute to left ventricular 
diastolic dysfunction.  
Although the prevalence of sleep apnea in patients with systolic heart failure 
has been systematically studied, the prevalence and the impact of OSA in diastolic 
heart failure need to be determined. In one study of (92) 20 patients with diastolic 
heart failure, approximately half of the patients had sleep apnea. It is speculated 
that OSA could be the cause of diastolic heart failure or the presence of OSA could 
contribute to the worsening of diastolic heart failure. In this regard, a preliminary 
study reports that the treatment of OSA improves diastolic dysfunction (84) which 
might be a significant finding. 
 
8 ARRYTHMIAS IN OSA 
Repetitive nocturnal apneas elicit severe derangements in cardiovascular 
homeostasis. Hypoxemia, hypercarbia, acidosis and adrenergic activation, 
increased afterload and rapid fluctuation in cardiac wall stress would reasonably 
contribute to tachycardia- bradycardia oscillations and atrial and ventricular 
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arrhythmias. A variety of AV arrhythmias including complete heart block and 
ventricular asystole during sleep have been observed in patients with OSA (93, 94, 
95) and have been eliminated by either tracheostomy or by nasal CPAP.(93, 94 ) 
Although the normal heart would be less likely to manifest malignant arrythmias, 
in the setting of severe obstructive apnea, the ischemic, hypertrophied or failing 
heart would be more succeptible (96). Nevertheles the activation of the diving 
reflex during apneas is very important in the genesis of arrhythmias. 
 
 
 
Tachycardia- bradycardia oscillations 
Patients undergoing Holter monitoring may be noted to have repetitive 
cyclic episodes of tachycardia and bradycardias during the night (97). These 
oscillations in cardiac rate are for the most part explained by changes in cardiac 
autonomic drive related to breathing pattern.  During the apnea, incremental 
hypoxemia elicits the diving reflex so that bradycardia becomes progressively 
more marked. With termination of apneas, hyperapneas occurs with consequent 
activation of thoracic afferents which is vagolytic (98). Thus with resumption of 
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breathing, abrupt lung inflation interrupts vagal drive to the heart, resulting in rapid 
onset tachycardia. 
 
Bradyarrythmias: 
The primary response to hypoxia is bradycardia. Patients with OSA may be 
particularly succeptible to hypoxia induced bradycardia, because their peripheral 
chemoreflex is heightened, so that even during voluntary apneas, hypoxia elicits 
greater bradycardia than is seen in closely matched control subjects (99).Moreover 
patients with OSA who also have systemic hypertension or cardiac failure may 
have even more severe bradycardic response to obstructive apnea. 
 
Ventricular arrhythmias:  
There is a potential contribution of OSA to ventricular arrhythmias through 
ventricular ectopy during profound bradycardia as well as polymorphic ventricular 
tachycardia due to cardiac hypoxia/ischemia. They are more common in patients 
with CAD and are virtually eliminated with treatment. Atrial fibrillation has also 
been associated with OSA 
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MATERIALS AND METHODS 
The study was conducted in the department of medicine and the department 
of physiology, Madras Medical College, during the period from August 2007 to 
August 2008. 
Patients attending Madras medical college and government general hospital 
medical outpatient department were considered for the study. 
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STUDY DESIGN:  
Cross – Sectional study to evaluate the occurrence of obstructive sleep apnea 
and hypopnea syndrome and its complications in obese individuals. 
STUDY DURATION: 
This study was conducted for a period of one year from August 2007 to 
August 2008. 
  INCLUSION CRITERIA: 
1. Age 21 – 60 years 
2. Body mass index (BMI) ≥30 Kg/m2 
3. Epworth sleepiness score ≥ 11 
 
  EXLUSION CRITERIA: 
1. Those with insufficient sleep 
2. Shift work 
3. Psychiatric disturbances( depression) 
4. Drugs ( Both stimulants and sedatives) 
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5. Narcolepsy 
A total of 60 patients were included in the study after fulfilling the criteria. Patients 
with BMI ≥ 30 Kg/m2 were subjected to Epworth s sleepiness scoring and those 
with a score of ≥ 11 were considered for the study and a total of 60 patients were 
included in the study. 
The subjects were interviewed in detail regarding the symptoms of sleep 
apnea namely snoring, fragmented sleep and excessive somnolence. Symptoms 
reported by the patients were confirmed by the relatives. 
 
 
 
POLYSOMNOGRAPHIC RECORDING: 
  All the 60 individuals were subjected to an overnight 8 hour 
polysomnography (RMS). It included twelve channels, two for EEG in C4A1 and 
C3A2 positions.Two electroocculogram on either sides, surface chin 
electromyogram, electrocardiogram, pulse oximetry for arterial oxygen saturation, 
thermistor to detect nasal airflow, respiratory inductance plethysmography for 
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abdominal and chest wall movements, microphone for objective recording of 
snoring. 
Polysomnographic recording was done from ten PM to six AM. All the subjects 
were asked to empty their bladder before the recording. Before application of 
electrodes, the skin was prepared with spirit. Sleep duration was defined as the 
total duration spent by the subjects in actual sleep that is exclusive of all the 
periods of awakenings in between. 
Sleep stage scoring was done for each 30 second scoring epoch using standard 
criterion. The presences of respiratory events were noted. They were defined as 
 
1.  Apnea              :       periods of cessation of nasal airflow lasting for atleast ten     
seconds 
2. Hypopnea     :         Reduction of airflow (70%) of  baseline for greater than      
10 seconds 
3. Obstructive sleep apnea:  periods of cessation of nasal airflow lasting for at 
least ten seconds, associated with continuing abdominal and chest wall 
movements. 
And the main parameter used to quantify the respiratory event was 
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1. Apnea- Hypopnea index (AHI): The average number of apneas/ hypopneas 
for each hour of sleep. 
2. AHI ≥ 5 was considered diagnostic of OSA. 
      For those individuals turning out to be positive for OSAHS a detailed search 
for the following complications were done 
1. Systemic Hypertension:  hypertension was defined as  
a) Known hypertensive on antihypertensive drugs 
b) A resting blood pressure greater than 140/90 mmHg  on two 
separate occasions measured by an approximate sized cuff 
2.  Pulmonary Hypertension: A diagnosis of pulmonary hypertension was made 
when the pulmonary arterial pressure was more than 25 mmHg as by ECHO. 
3. Coronary Arterial disease: ECG and/or ECHO evidence of coronary arterial 
disease in the form of ST/ T changes or Regional wall motion abnormalities 
in ECHO. 
4. Ventricular dysfunction: Diastolic/ systolic dysfunction as measured by 
ECHO. 
5. Increases Packed cell volume( PCV ): PCV ≥ 50% 
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6. Diabetes Mellitus: Known diabetics on drugs or Fasting blood sugar >126 
mg% and/or 2 hour post glucose tolerance test value >200mg% 
 
 
 
 
 
 
 
 OBSERVATIONS 
BASELINE CHARACTERISTICS: 
In this study 60 subjects participated (Obese individuals with an Epworth 
sleepiness score ≥ 11) 
 TABLE 1: 
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Among the individuals participated seven were in the 21-30 age group 
(11.66%) and twenty two were in the 31- 40 year age group (36.6%). Similarly 
eighteen individuals (30%) and thirteen individuals (21.66%) were in the 41-50 
and 51-60 year age group respectively. 
  TABLE 2: 
Fourty two individuals were males (70%) and eighteen were females (30%). 
  TABLE 3:  
The mean BMI was 35.5 and majority of the subjects were in the BMI of 31-
40 (fifty five subjects which comes to around 91.66%) and the rest were in the 
BMI above 40. (8.33%) 
  
 
ANALYSIS OF SYMPTOMS:  
TABLE 4: 
Snoring was the major symptom analyzed and twenty five subjects who 
underwent the polysomnography had snoring. Of the twenty patients who were 
50 
 
diagnosed to have OSA as per polysomnography fifteen had snoring (66.6%) as 
told by them or their bed partners. 
RESULTS FROM THE POLYSOMNOGRAPHIC STUDY: 
 TABLE  5: 
The polysomnographic study showed that twenty out of sixty patients 
(33.3%) had OSA as defined by an AHI ≥ 5. 
TABLE 5: 
The distribution of AHI among the study population was 
1. Forty subjects had AHI <5 (66.66%) 
2. Thirteen subjects had AHI between five and fifteen (21%) 
3. Seven subjects had AHI> fifteen (11.66%) 
 
TABLE 6: 
Among eighteen females who participated in the study ten had OSAHS 
(55.55%), and among the forty-two males who participated ten had OSAHS 
(23.80%). 
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TABLE 7: 
Out of the twenty subjects who turned positive for OSAHS as per the 
polysomnography, none of them were in the 21 -30 year age group. Four out of the 
twenty two subjects (18.18%) in the 31-40 year age group had OSAHS. Similarly 
six of the eighteen individuals (33.33%) and ten of the thirteen individuals 
(76.92%) in the 41-50 year and 51-60 year age group had OSAHS respectively. 
TABLE 8: 
Of the twenty individuals who turned positive for OSAHS thirteen had mild 
and seven had severe OSAHS respectively. 
TABLE 9: 
Three out of the five individuals with BMI ≥ 40 who participated had 
OSAHS (60%) as opposed to seventeen of the fifty-five individuals with BMI 
between 31-40 (30.90%) 
 
PREVALENCE OF VARIOUS COMPLICATIONS: 
 
TABLE 10: 
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Of the twenty individuals who had OSAHS, eight (40%) had systemic 
hypertension as documented by a blood pressure > 140/90mmHg measured on two 
separate occasions with an appropriate sized cuff. One had isolated systolic 
hypertension, three had isolated diastolic hypertension and four had combined 
systolic and diastolic hypertension. (TABLE 11) 
TABLE 12: 
Three (15%) among the twenty subjects with OSAHS had Pulmonary 
arterial hypertension as documented by a pulmonary arterial pressure > 25 mmHg 
as per ECHO. 
TABLE 13: 
Five of the twenty patients had a Packed cell volume >50% (25%). 
TABLE 14: 
Six subjects (30%) with OSA had evidence of coronary artery disease as by 
ECG and/or ECHO. 
TABLE 15: 
Five (25%) of the twenty patients with OSAHS had evidence for systolic 
and/ or diastolic dysfunction as per ECHO. 
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TABLE 16: 
Five subjects (25%) had diabetes mellitus out of the twenty who had 
OSAHS. Of them two are known diabetics who were already on drugs and three 
were diagnosed to have high blood sugars now. 
TABLE 17: 
This table summarizes the prevalence of various complications associated 
with OSAHS. 
Figure 2 shows the age and sex distribution of OSAHS among the individuals 
studied. 
Figure 4 is a simple schematic diagram showing the relationship between OSAHS 
and the complications associated with it. 
Figure 3 show the prevalence of cardiovascular risks over a seven year period in 
normal individuals as compared to ineffectively treated and completely treated 
OSAHS. 
A Polysomnographic tracing showing the various parameters monitored 
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A Polysomnographic tracing showing an episode of Obstructive sleep Apnea 
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TABLES AND CHARTS 
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Age distribution of individuals who participated in the study:  Table 1 
 
 
 
 
Sex distribution of individuals who participated in the study: Table 2 
Sex Male Female Total 
Number of 
individuals 
42 18 60 
 
 
 
BMI of individuals who participated in the study: Table 3 
Age group 21-30 31-40 41-50 51-60 
Number of 
individuals 
7 22 18 13 
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BMI 30-40 >40 
Number of individuals 55 5 
 
 
 
 
Snoring and OSAHS: Table 4 
 OSAHS (n=20) Non-Apneics  (n=40) 
Snoring 15 10 
No Snoring 5 30 
 
In patients with BMI ≥30kg/m2, snorers have a 9 times higher chance of having 
sleep apnea. 
 
AHI of the subjects who participated in the study: Table 5 
AHI 0-5 5-15 >15 
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Number of patients 40 13 7 
 
 
 
 
Figure 1: 
 
 
 
59 
 
Subjects who had OSAHS: Table x 
 AHI <5 AHI>5 
Number of subjects 40 20 
Percentage of subjects who had OSAHS = 33.3% 
 
 
 
 
Sex distribution of patients who turned positive for OSAHS: Table 6 
 Males Females Total 
Subjects 
participated 
42 18 60 
OSAHS 10 10 20 
Percentage 23.80% 55.55% 33.33% 
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Age distribution of subjects who had OSAHS: Table 7 
Age group 21-30 31-40 41-50 51-60 
Subjects 
participated 
7 22 18 13 
OSAHS - 4 6 10 
Percentage - 18.18% 33.33% 76.92% 
 
 
 
 
Severity of OSA: Table 8 
AHI 5-15(mild to moderate OSA) >15 (severe OSA) 
Number of subjects 13 7 
 
 
 
BMI and OSAHS: Table 9 
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BMI >40 30-40 
Number of subjects 
participated 
5 55 
Positive for OSA 3 17 
Negative for OSA 2 38 
 
 
 
 
Blood pressure in patients with OSAHS: Table 10 
Blood pressure <140/90 >140/90 
Number of subjects 12 8 
Percentage of individuals with hypertension: 40% 
 
 
 
Table 11: 
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Systolic hypertension Diastolic hypertension Combined hypertension 
N=1 N=3 N=4 
 
 
 
 
 
 
Pulmonary hypertension and OSAHS: Table 12 
Pulmonary artery pressure <20mmhg >20mmhg 
Number of subjects 17 3 
Percentage of individuals with Pulmonary Hypertension: 15% 
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PCV and OSAHS: Table 13 
PCV <50% >50% 
Number of subjects 15 5 
Percentage of individuals with PVC > 50%: 25% 
 
 
 
 
 
CAD and OSAHS: Table 14 
CAD(ECG and/or ECHO) Yes No 
Number of subjects 6 14 
Percentage of individuals with CAD: 30% 
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Systolic/Diastolic dysfunction and OSAHS: Table 15 
Ventricular dysfunction Yes No 
Number of subjects 5 15 
 
 
 
 
 
Diabetes Mellitus and OASHS: Table 16: 
Diabetes Mellitus Yes No 
Number of subjects 5 15 
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Age and sex distribution of subjects with OSA 
 
 
 
 
 
 
Figure 2: 
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Figure 3: 
Incidence of cardiovascular risk – A 7 yr follow-up study 
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Figure 4: 
Schematic of OSAHS and its complications 
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Table 17: 
Prevalence of various complications of OSAHS 
Complications Percentage (%) 
Systemic hypertension 40% 
Pulmonary hypertension 15% 
Coronary artery disease 30% 
Ventricular dysfunction 25% 
Diabetes Mellitus 25% 
↑PCV 25% 
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DISCUSSION 
Despite being an increasingly recognized entity in the western world, 
OSAHS is still not a commonly made diagnosis as far as our part of the country is 
concerned. As we could not get much literature on this as far as our population is 
concerned, we have planned to look out for the occurrence of OSAHS in obese 
individuals with excessive daytime somnolence as evidenced by an Epworth’s 
sleepiness score ≥11. 
The Prevalence of sleep apnea is reported to be approximately 30 %( 23, 24 
25) in the obese population and about 2.4%in the general population. 
OSA is known to produce a multitude of complications starting from 
systemic hypertension to coronary artery disease and stroke etc. For example 
obesity predisposes to OSA and hypertension is also common due to various 
metabolic factors in obese subjects. There is increasing evidence that sleep apnea 
leads initially to nocturnal and later to daytime sustained hypertension. 
We studied a group of obese individuals aged 21-60 years with an Epworth’s 
score ≥ 11. 
The occurrence of sleep apnea as per our study is 33.33% which is similar to 
many other studies in the western population (23, 24, 25). The prevalence is known 
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to increase with increasing age and age is supposed to be the most important 
predictor for the occurrence of OSAHS. We studied subjects in the age group from 
21-60 and none of the subjects in the age group 21-30 had OSA as opposed to 
76.92% of patients in the age group of 51-60 and 33.33% of subjects in the 41-50 
year age group. In concordance with other studies age seems to be the single most 
important factor in the causation of OSAHS. 
Ours is a male predominant study which contained 42 males and 18 females. 
The occurrence of OSA was higher in females as compared to the males (55.55% 
as against 27.80%). This is in contrast to other studies which generally report a 
higher prevalence in males as compared to females. The risk in women generally 
increases with obesity and postmenopausal state. This ratio may not be applicable 
to the UARS (Upper airway resistance syndrome) patients, where the ratio is close 
to 1:1. 
Obesity also appears to be another important factor for OSAHS and the 
prevalence increases with increase in BMI. In our study too, the occurrence rate 
was around 60% in those with BMI > 40 as compared to 30.9% in those with a 
BMI between 30 – 40. In one study a BMI of atleast 25kg/m2 had a sensitivity of 
93% and a specificity of 74% for OSAHS (100). Thus it becomes important the 
diagnosis is thought of in individuals with a high BMI and with the symptoms. 
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Similarly excessive daytime sleepiness is an important symptom without 
which we will not be diagnosing OSAHS whatever may be the AHI. This was 
ascertained in our study by the Epworths sleepiness score (a score ≥11 was 
considered significant) (101). 
Snoring seems to be another important symptom which can give us a clue 
regarding the presence of OSAHS though not all patients with snoring will have 
OSAHS. In our study snoring was present in 66% of the apneics as against 25% of 
the non-apneics and the odds ratio for individuals with snoring and OSAHS is 9 
(Table 4). 
OSAHS is associated with a number of complications many of which are 
correctable once treatmenr for OSAHS is started. 
As many as half of the patients with sleep apnea may have underlying 
hypertension and many patients with hypertension, particularly resistant 
hypertension may have OSAHS.  Infact there seems to be an interaction between 
OSA severity and resistance to Medications (102). Whether hypertension 
contributes to OSA remains unclear. 
OSAHS patients maynot always have elevated systolic Blood pressure but 
may have high prevalence of isolated diastolic hypertension (103). One study 
suggested that there was a significant association between the incidence of 
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combined systolic and diastolic hypertension and the prevalence of sleep apnea in 
younger patients (< 60 years of age) but not in older patients (104). The prevalence 
of hypertension in our group was 40 %( n=80) (table 10) and most of the patients 
had combined systolic and diastolic hypertension (Table 11). 
According to a study the four year incidence of hypertension was 31.5% as 
compared to 9.7% in OSAHS as compared to normals (105). 
Various studies have documented an impressive reduction in systolic blood 
pressure with continuous positive airway pressure (CPAP) (106). 
The prevalence of pulmonary hypertension is high in patients with OSAHS 
and it has been confirmed in many studies. An early study (107) in twelve patients 
with OSA who had undergone right heart catheterization showed cyclic changes in 
pulmonary artery pressure coinciding with episodes of OSA. Marked degree of 
hypoxemia and hypercapnia was associated with these hemodynamic 
abnormalities. In some of these patients the pulmonary arterial pressure exceeded 
60mmhg. In some of these patients exercise increased the pulmonary capillary 
wedge pressure, unmasking left ventricular diastolic dysfunction. In our study the 
prevalence of pulmonary hypertension was 15% and was comparable to other 
studies which varies from 15-70% (108) and again CPAP treatment effectively 
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reduced the pulmonary artery pressure (109). Chaouat et al, Laks et al have done 
major works as far as the pulmonary hypertension and OSA is concerned. 
Patients with OSAHS have a high prevalence of coronary artery disease and 
vice versa. The case control study of Perker et al (110) in a multiple logistic 
regression model showed that the presence of OSAHS remained independently 
associated with CAD (odds ratio 3.1 vs 9.8). The large Swedish cohort study of 
Moore et al (111) also suggests that OSA was much more prevalent in individuals 
with established CAD than in controls. Cross sectional reports from the population 
based sleep heart health study (112) showed that in patients with OSAHS the 
multivariable adjusted odds (95% limits) with self reported CAD was a more 
modest 1.27 (0.99 to 1.62) (comparing upper with lower quartiles of severity of 
sleep disordered breathing). The prevalence of OSA in our study was 30% which is 
in concordance with many other studies where the prevalence varies from 20-70 
%( 113). 
Left ventricular dysfunction is more common in OSAHS (114) and OSA is 
also more common in patients with Left ventricular dysfunction (115). The 
prevalence ranges from 32 -50% (114) in different studies. Alchantis et al (116) 
studied 29 patients with severe OSA and 12 control subjects. The mean left 
ventricular ejection fraction was significantly lower in patients with OSA 
compared with the control group (52% versus 61%). After treatment with CPAP 
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the left ventriculat ejection fraction increased significantly to 56%. Left ventricular 
diastolic dysfunction also improved significantly. Jawaheri et al (117) found that 
12 % of patients with Left ventricular ejection fraction < 45% have severe 
OSAHS. The sleep heart health study found that heart failure was 2.38 times more 
prevalent in mild to moderate OSA than in controls (112). The prevalence in our 
study group is 25% which is in accordance with the studies cited above. 
Diabetes is more common in OSAHS and Diabetics are more prone to 
develop OSAHS. The occurrence of diabetes in our study group was 25%. Many 
studies have already found an undisputable correlation between OSAHS and 
Diabetes and the main evidence comes from two studies. In the first study, habitual 
snoring in 2668 Swedish men was associated with a higher incidence of self 
reported diabetes over a 10 year period. Obesity and habitual snoring were noted to 
be additive in their associated risks for type 2 diabetes. The major limitation of that 
study was that self-reports were used to asses diabetes and sleep apnea status. The 
pitfalls were subsequently addressed by data from the nurses’ health study, in 
which the diagnosis of type 2 diabetes was made objectively. The relative risk for 
diabetes comparing regular snorers to non snorers was 2.03(95% confidence limits) 
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As far as the association between an increase in hematocrit and OSAHS is 
concerned further studies need to be done to support or to refute a causal 
association between the two. As of now there are quite a few studies which points 
to the hypoxia induced by OSAHS as a potential factor in the increased hematocrit 
cited. In our group 25% of the patients with OSAHS had a hematocrit more than 
50% which goes very well in concordance with the works of J B Choi (118). 
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LIMITATIONS OF THIS STUDY 
 
1. Since we have decided to just study the prevalence of various complications 
associated with OSAHS, we have not taken any controls. Had we taken 
controls, the association would have become even stronger. 
2. Blood pressure was measured by ambulatory Blood pressure monitoring, 
measured the previous day and not on the night during polysomnography. 
This was done to avoid any sleep disturbance due to cuff inflation leading to 
arousal and hence affecting the polysomnographic data. 
3. It would have been ideal to have monitored the BP using invasive 
techniques.This was not attempted for ethical reasons. However , since the 
ambulatory BP monitoring device could not be used  while doing 
polysomnography recording, data regarding the stages of sleep viz a viz BP 
could not be obtained. 
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CONCLUSION 
 
1. The occurrence of  OSAHS in obese individuals with excessive daytime 
somnolence is 33.33% 
2. The prevalence increases with age 
3. Both the sexes are equally susceptible 
4. Snoring is a common symptom and is present in 75% of individuals with 
OSAHS 
5. Systemic hypertension, pulmonary hypertension, coronary artery disease, Left 
ventricular dysfunction, Diabetes and high PCV are all associated with 
OSAHS. 
6. The prevalence of the above mentioned complications is comparable with other 
studies done so far. 
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SUMMARY 
 
Obstructive sleep apnea syndrome is known to occur in about 30% of obese 
individuals and is also known to be associated with a number of complications. 
This study was undertaken as there are only limited data regarding the prevalence 
of this condition and the complications associated with it. A total of 60 obese 
individuals with excessive daytime somnolence as ascertained by an Epworth score 
greater than 11 were studied and a eight hour overnight polysomnographic 
recording was done and among the individuals who turned positive for OSAHS, 
various complications were assessed for their presence. 
The occurrence of OSAHS was found to be about 33.33%. The prevalence 
of various complications were, systemic hypertension: 40%, Pulmonary 
hypertension: 15%, CAD: 30%, Ventricular dysfunction: 25%, Diabetes mellitus: 
25%, elevated PCV: 25%. 
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                        ABBREVIATIONS 
OSAHS        -   Obstructive sleep apnea- Hypopnea syndrome 
UARS          -   Upper airway resistance syndrome 
REM            -   Rapid eye movement 
EEG             -   Electroencephalogram 
EOG             -   Electroocculogram 
EMG             -  Electromyogram 
BP                 -  Blood  Pressure 
AHI               -  Apnea Hypopnea Index 
BMI               -  Body mass Index 
CPAP             - Continuous Positive airway pressure 
PAH               -  Pulmonary arterial hypertension 
LV                  -  Left Ventricle 
CAD               -  Coronary Arterial Disease 
DM                 -  Diabetes Mellitus 
SHT                -  Systemic Hypertension 
FBS                 - Fasting blood sugar 
PPBS               - Post Prandial blood sugar 
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PROFORMA 
OCCURRENCE OF OBSTRUCTIVE SLEEP APNEA/HYPOPNEA 
SYNDROME AND ITS COMPLICATIONS IN OBESE INDIVIDUALS 
 
NAME: 
AGE: 
SEX: 
BMI: 
EPWORTH’S SLEEPINESS SCORE: 
 
HISTORY:   1) History of snoring (self reported or by bed partner) 
2) History of polyuria (more than one awakening in night for           
micturition) 
EXAMINATION: 
        Detailed general examination including 
a) Height, weight and BMI 
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b) Neck circumference 
c) Anaemia, cyanosis, pedal edema. 
Cardiac examination in detail: 
a) Pulse 
b) Blood Pressure 
c) Jugular venous pressure 
d) S1 ,S2 ,  P2 
e) Added sounds 
        Respiratory examination in detail: 
a) Examination of thoracic cage for any deformity 
b) Tracheal position 
c) Breath sounds 
d) Added sounds 
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POLYSOMNOGRAPHY: 
AHI: 
Analysis of complications in those with OSAHS: 
1)  Blood pressure (measured twice on two different occasions 24 hours apart) 
2) Electrocardiogram 
3) Echocardiogram 
4) Pulmonary arterial pressure measured by ECHO 
5) Packed cell volume 
6) Blood sugar ( Fasting and 2 hour post Glucose tolerance test ) 
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EPWORTH’S SLEEPINESS SCORE: 
 0 = would never dose 
 1 = Slight chance of dosing 
 2 = Moderate chance of dosing 
 3 = High chance of dosing 
  
a) Sitting and reading 
b) Watching TV 
c) Sitting inactive in a public place ( eg: in a theatre or at a meeting) 
d) As a passenger in a car for one hour without break 
e) Lying down to rest in the afternoon 
f) Sitting and talking to someone 
g) Sitting quietly after lunch without alcohol 
h) In a car, while stopping for a few minutes in traffic 
Total score: 
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Patient consent form 
Study Title: 
“Occurrence of Obstructive sleep apnea and its complications in obese individuals”  
Study centre                  :  Institute of Internal Medicine ,Madras Medical College. 
Patient’s Name              : 
Patient’s Age                  : 
Identification Number: 
                                                                                                 Patients may check (   ) these Boxes 
I confirm that I have understood the purpose of procedure for the above study. I have the 
opportunity to ask the questions and all my questions and doubts have been answered to my 
complete satisfaction.                                                                                                                                             
[    ] 
I understand that my participation in the study is voluntary and that I am free to withdraw at 
any time without giving any reason , without my legal rights being affected.                                               
[    ] 
I understand that the sponsor of the clinical study, others working on the sponsor’s behalf, the 
ethics committee and the regulatory authorities will not need my permission to look at my 
health records both in respect of the current study and any further research that may be 
conducted in relation to it, even if I withdraw from study. I agree to this access. However, I 
understand that my identitiy would not be revealed, in any information released to third parties 
or published,unless as required under the law. I agree not to restrict the use of any data or 
results that arise from this study.                                                                    
              [     ] 
I agree to take part in the above study and to comply with the instructions given during the 
study and to faithfully to co‐operate with the study team, and to immediately  inform the  study 
staff if I suffer from any deterioration in my health or my wellbeing or any unexpected or 
unusual symptoms.                                          
[     ] 
I hereby give consent to participate in this study looking for the prevalence of obstructive sleep 
apnea and its complications in obese individuals. I have understood that as a part of this study I 
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will be required to sleep for eight hours in the night with various medical equipments attached.         
[     ] 
Signature /Thumb impression  
Of the patient                                    :      Place: 
Patient’s name and address: ……………………………………………………………. 
 Signature of the investigatior: …………………………….    Place…………………………. 
Date………. 
                                                           MASTER CHART 
AHI  of Individuals who participated in the study 
S.No Age Sex 
Epworth 
score AHI 
Sleep 
duration Snoring BMI 
1 48 M 13 4 6 N 35 
2 25 M 14 2 6 N 38 
3 58 F 12 3 7 N 32 
4 52 M 14 17 8 y 38 
5 42 M 15 3 7 N 33 
6 55 M 12 18 8 y 34 
7 57 M 14 16 7 y 38 
8 42 F 13 4 8 N 36 
9 50 F 12 14 8 y 35 
10 39 F 11 16 8 y 33 
11 30 M 12 4 6 N 32 
12 30 M 11 3 7 y 32 
13 33 M 12 2 8 y 33 
14 54 M 13 13 8 y 33 
15 60 M 13 15 8 y 35 
16 36 F 13 3 8 N 33 
17 45 M 12 3 7 N 36 
18 40 M 12 4 7 N 32 
19 30 M 12 2 6 y 33 
20 50 M 13 16 8 y 34 
21 58 F 14 12 8 y 35 
22 53 F 14 8 6 y 35 
23 28 M 14 1 7 N 31 
24 38 M 17 3 8 y 31 
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25 35 M 16 2 8 N 32 
26 42 M 16 13 8 y 32 
27 35 M 12 3 8 y 33 
28 40 M 12 2 8 N 38 
29 29 M 11 4 8 N 41 
30 30 M 12 4 7 N 32 
31 48 M 13 4 7 N 31 
32 40 M 13 2 6 N 33 
. 
 
 
 
AHI of Individuals who participated in the study 
S.No Age Sex 
Epworth 
score AHI 
Sleep 
duration Snoring BMI 
33 46 M 14 2 8 N 33 
34 58 F 14 11 7 y 33 
35 57 M 11 3 8 y 36 
36 50 F 12 3 8 N 32 
37 55 M 12 4 8 N 31 
38 44 M 12 7 8 y 32 
39 45 M 13 12 8 y 35 
40 36 F 13 4 8 y 33 
41 37 M 12 3 8 N 35 
42 36 M 11 1 7 y 33 
43 37 M 14 7 8 y 38 
44 45 M 12 3 7 N 34 
45 40 M 12 2 6 N 33 
46 55 F 14 8 8 y 35 
47 45 M 12 3 6 y 35 
48 38 M 12 1 7 y 32 
49 38 F 12 2 8 N 38 
50 40 F 17 18 8 y 49 
51 35 F 12 1 8 N 40 
52 39 F 12 11 8 y 42 
53 56 F 13 8 7 y 37 
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54 50 F 13 2 8 N 35 
55 40 M 16 2 8 N 31 
56 45 M 14 12 8 y 40 
57 40 M 12 2 7 N 35 
58 36 M 12 1 7 N 33 
59 44 M 12 4 7 N 36 
60 50 M 13 3 8 N 32 
 
 
 
 
 
AHI of Individuals who turned positive for OSAHS 
S.No Age Sex BMI AHI 
Sleep 
duration 
1 52 M 38 17 8 
2 55 M 34 18 8 
3 57 M 38 16 8 
4 50 M 35 14 7 
5 39 M 33 16 8 
6 54 M 33 13 7 
7 60 M 35 15 8 
8 40 F 49 18 6 
9 39 F 42 11 8 
10 50 M 34 16 7 
11 58 F 35 12 8 
12 53 M 35 8 8 
13 42 M 32 13 8 
14 56 M 37 8 7 
15 45 M 40 12 7 
16 58 F 33 11 7 
17 44 F 32 7 7 
18 45 M 35 12 8 
19 37 M 38 7 8 
20 55 F 35 8 7 
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Prevalence of various complications in individuals with OSAHS 
S.No Age Sex BMI AHI 
Sleep 
duration BP PCV CAD 
LV 
dysfunction PAP FBS PPB
1 52 M 38 17 8 150/100 37 N Y 30 110 130
2 55 M 34 18 8 140/100 52 Y N 17 90 150
3 57 M 38 16 8 130/100 45 Y Y 12 80 140
4 50 M 35 14 7 126/86 38 N N 18 75 138
5 39 M 33 16 8 134/84 50 Y Y 17 85 128
6 54 M 33 13 7 146/96 42 N N 16 95 138
7 60 M 35 15 8 120/80 48 N N 15 100 130
8 40 F 49 18 6 126/86 52 N N 12 104 140
9 39 F 42 11 8 130/80 38 N N 13 140 220
10 50 M 34 16 7 158/88 54 Y N 14 90 160
11 58 F 35 12 8 150/104 34 N N 15 120 260
12 53 M 35 8 8 148/100 32 N N 15 80 160
13 42 M 32 13 8 110/84 45 N N 16 130 250
14 56 M 37 8 7 136/88 51 N N 13 90 150
15 45 M 40 12 7 126/80 38 N Y 28 75 140
16 58 F 33 11 7 120/86 45 Y N 15 135 225
17 44 F 32 7 7 110/70 39 N N 12 80 140
18 45 M 35 12 8 130/100 45 Y Y 34 80 138
19 37 M 38 7 8 130/86 42 N N 15 120 210
20 55 F 35 8 7 120/86 42 N N 18 90 130
 
 
